| 1 |
Oral treprostinil (ut-15c) sustained release tablets |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
| 2 |
Ut-15c |
- |
- |
- |
- |
086 [1] 86 💬 |
| 3 |
Ut-15c (treprostinil diethanolamine) |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
| 4 |
Ut-15c 0.25 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
| 5 |
Ut-15c 1 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
| 6 |
Ut-15c 5 mg |
- |
- |
- |
- |
086 [1] 86 💬 |
| 7 |
Ut-15c lp |
- |
- |
- |
- |
086 [1] 86 💬 |
| 8 |
Ut-15c sr |
- |
- |
- |
- |
051 [2] 51, 86 💬 |
| 9 |
Ut-15c sr (treprostinil diethanolamine) |
Treprostinil |
[1] D06213 D06213 💬 |
PTGIR [1] PTGIR 💬 |
Neuroactive ligand-receptor interaction [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction |
086 [1] 86 💬 |
| 10 |
Ut-15c-sr |
- |
- |
- |
- |
051 [2] 51, 86 💬 |